Dr. Bernard Brais

A message from Dr. Brais

In Latest News by ARSACS

 

“The high throughput screening platform of the Institute for Research in Immunology and Cancerology (IRIC) is accelerating its screening of molecules using a model derived from fibroblasts of patients with ARSACS. This fall they screened more than 12 000 molecules tested! The validations will follow in early 2018. Because the research is healing! Merry Christmas”.